论文部分内容阅读
目的探讨并比较左胸路径、右胸路径治疗胸中段食管癌患者的疗效。方法 88例胸中段食管癌患者,按照序号分为观察组和对照组,每组44例。对照组给予左胸路径治疗,观察组给予右胸路径治疗,比较两组的临床指标及并发症、3年复发情况。结果观察组患者的住院时间(17.21±4.06)d、手术时间(223.4±10.3)min明显短于对照组的(22.46±3.32)d、(303.3±11.1)min,术中出血量(400.7±12.1)ml明显少于对照组(523.4±10.2)ml,淋巴结清除量(50.4±8.5)个明显多于对照组(38.7±5.5)个,差异均具有统计学意义(P<0.05)。术后,观察组并发症发生率22.73%略低于对照组的27.27%,但差异无统计学意义(P>0.05);行3年随访发现,观察组复发率31.82%明显低于对照组的65.91%,差异具有统计学意义(P<0.05)。结论右胸路径治疗胸中段食管癌疗效更为显著,能有效降低术后复发率,值得临床应用。
Objective To investigate and compare the curative effect of left chest path and right chest path in the treatment of middle and thoracic esophageal cancer patients. Methods 88 cases of middle and upper esophageal cancer patients were divided into observation group and control group with 44 cases in each group. The control group was treated with left chest path. The observation group was treated with right chest path. The clinical indexes and complications of the two groups were compared. The recurrence was observed in 3 years. Results The length of hospital stay (17.21 ± 4.06) days and the operative time (223.4 ± 10.3) min in the observation group were significantly shorter than those in the control group (22.46 ± 3.32) and (303.3 ± 11.1) min respectively. The intraoperative blood loss (400.7 ± 12.1) ) was significantly lower than that of the control group (523.4 ± 10.2) ml, and the lymph node clearance (50.4 ± 8.5) was significantly higher than that of the control group (38.7 ± 5.5), the difference was statistically significant (P <0.05). Postoperatively, the complication rate of observation group was 22.73%, which was slightly lower than that of control group (27.27%), but the difference was not statistically significant (P> 0.05). At 3-year follow-up, the recurrence rate of observation group was significantly lower than that of control group 65.91%, the difference was statistically significant (P <0.05). Conclusion The right chest path is more effective in treating thoracic esophageal cancer, which can effectively reduce the postoperative recurrence rate, which is worthy of clinical application.